Bioequivalence of Miglustat capsule
Not Applicable
Recruiting
- Conditions
- .
- Registration Number
- IRCT20210201050197N7
- Lead Sponsor
- Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 24
Inclusion Criteria
Healthy volunteer
Age_18-50 year
Exclusion Criteria
History of liver, kidney and cardiovascular diseases that can affect drug clearance from body
History of taking any medication in the last two weeks
Creatinine above 2
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Maximum plasma concentration of the drug. Timepoint: Before intervention and 0.5, 1, 1.5, 2, 2.5, 3, 4, 6, 8, 10, 12 and 24 hours after intervention. Method of measurement: liquid chromatography-mass (LC-MS) device.
- Secondary Outcome Measures
Name Time Method